Virtual education: Food and common cancer myths

March 14, 2024 Providence Cancer Institute of Oregon

Providence Cancer Institute in partnership with Pink Lemonade Project presented a free virtual education talk on food and common cancer myths. Christina Speaks, MS, RDN, LD, a registered dietitian at Providence Cancer Institute, Oncology Nutrition, was the guest speaker.

About Christina Speaks:

Christina’s journey in nutrition began at Sam Houston State University in Huntsville, TX, where she completed her undergraduate and master’s degrees with a primary focus in nutrition research and community. She has spent a large part of her career in clinical nutrition, including critical care. Christina enjoys helping people feel confident and knowledgeable about the foods they eat. When she is not working, Christina enjoys distance running, hiking, camping and spending time with her husband and three sons.

About Providence oncology nutrition services:

Good nutrition is important during cancer treatment and recovery. Cancer and cancer treatments can affect the way your body tolerates certain foods and uses nutrients. Our registered dietitians specialize in cancer nutrition. They work closely with you to set nutrition goals and advise ways to achieve them. Learn more.

Keep your colon healthy to prevent disease

Welcome to your journey for creating a healthier you

Virtual education: Food and common cancer myths

Previous Article

Next Article

Virtual education: Food and common cancer myths

Previous Article

Next Article

Most Recent Articles

When a stroke robbed Lauren of her balance, the team on 4K – Providence Acute Rehabilitation Center – helped her regain what she lost with a little help from sunflowers, marigolds and little bugs.

The bariatric programs at Providence Little Company of Mary’s San Pedro and Torrance locations offer effective, long-term weight-loss solutions.

Providence South Division Cancer Institute earns national recognition as a top cancer program

Hospital program the only one recognized in Greater L.A. Area

More than 2,000 years ago, Hippocrates—the father of modern medicine—suggested that all diseases begin in the gut. With mounting evidence showing a connection between gut health and everything from au

Grounding allows us to use the earth’s negative electric charge to stabilize and rebalance our body’s accumulated positive charges. Contact with the vast supply of electrons on the earth’s surface—thi

Despite the sometimes dramatic improvements that have been made in other cancers, lung cancer survival has only slightly improved over the past several decades. Fortunately, that’s beginning to change

Rob Sears had been troubled by an increasingly erratic heartbeat for years. He finally found help from Dr. Shephal Doshi and a leading-edge minimally invasive procedure.

A special request for our patients and visitors – Farsi and Spanish translation further below:

R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.

The team at the Adult and Pediatric Cochlear Implant Program, Dr. Courtney Voelker and Dr. Rebecca Lewis, restored Father Timothy McGowan’s hearing so he could get back to the work he loves.

Kadlec offering Prevention4ME for detection of breast and other cancers.

The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.

In 2023, Providence Alaska contributed $265,000 to Catholic Social Services’ Medical Respite program, which provides recuperative living quarters for patients experiencing homelessness.

Learn why a proposed FSED is not right for our community.

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.